{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:28:29Z","timestamp":1765826909347,"version":"build-2065373602"},"reference-count":26,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To determine whether assessing seroprotection after influenza vaccine and administering booster vaccination where not achieved reduces hospitalization and death. To estimate the overall seroprotection rate of influenza vaccine.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    A two\u2010arm, partially blind, randomized, multicenter, parallel\u2010group, controlled trial.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Twenty\u2010six care homes in three South London boroughs in fall 2004.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    Two hundred seventy\u2010seven elderly permanent care home residents meeting eligibility criteria.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>INTERVENTION:<\/jats:bold>\n                    Postvaccination blood samples were randomized to booster evaluation or no booster evaluation (control). If evaluation revealed inadequate seroprotection, a booster vaccine was administered.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    Primary outcome was hospitalization to end April 2005; secondary outcomes were death, antibiotic use, and seroprotection.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    Sixty percent of the controls and 41% of the booster evaluation group responded to routine vaccination. Booster vaccination where indicated increased seroprotection rates in the booster evaluation group to 66%. Treatment groups did not differ in any outcome measures in the intention\u2010to\u2010treat analysis (hospitalization odds ratio=1.02, 95% confidence interval=0.55\u20131.87). There was a tendency towards greater differences between groups in the per\u2010protocol analysis than in the intention\u2010to\u2010treat analysis, particularly regarding seroprotection rates. The same effect was observed in the a priori exploratory analysis of residents not seroprotected after routine vaccination alone.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    In a year without circulating influenza, there is no clinical benefit of administering a booster vaccine if routine trivalent vaccination fails to result in seroprotection. Hemagglutination titers rose in two strains postbooster vaccination but fell against the novel strain, Wyoming. The benefit of such a booster strategy when influenza is prevalent thus remains unc ertain.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2007.01471.x","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T19:15:40Z","timestamp":1260386140000},"page":"1912-1920","source":"Crossref","is-referenced-by-count":12,"title":["Flu: Effect of Vaccine in Elderly Care Home Residents: A Randomized Trial"],"prefix":"10.1111","volume":"55","author":[{"given":"Fiona","family":"Gaughran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Walwyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Lambkin\u2010Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Chatterton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Oxford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Flu\u2014Effect of Vaccine in Elderly Residents Trial team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91434-X"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268896007121"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-7-199510010-00008"},{"key":"e_1_2_7_5_2","first-page":"230","article-title":"Influenza vaccines. WHO position paper","volume":"77","author":"World Health Organization.","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_7_6_2","first-page":"912","article-title":"Influenza vaccination","volume":"333","author":"Jefferson T.","year":"2006","journal-title":"Policy versus evidence"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/31.1.58"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91193-2"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-194911000-00001"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)06098-X"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.7.3043"},{"key":"e_1_2_7_12_2","unstructured":"GaughranF EdgarS MacdonaldAet al. Response to influenza vaccine in residential old age psychiatry patients. 7th International Symposium on Respiratory Viral Infections. Curacao Dutch Antilles 3\u20136 March 2005."},{"key":"e_1_2_7_13_2","first-page":"200","article-title":"Influenza subunit vaccine","volume":"1","author":"MacKenzie JS.","year":"1977","journal-title":"Antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200104)63:4<293::AID-JMV1004>3.0.CO;2-C"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.080"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/jcm.25.9.1763-1765.1987","article-title":"Immunization of elderly people with two doses of influenza vaccine","volume":"25","author":"Gross PA","year":"1987","journal-title":"J Clin Microbiol"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90038-8"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529712"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/cdli.2.1.120-121.1995","article-title":"Time to peak serum antibody response to influenza vaccine","volume":"2","author":"Rastogi S","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_7_21_2","first-page":"539","volume-title":"Vaccines","author":"Kilbourne ED","year":"1999"},{"key":"e_1_2_7_22_2","unstructured":"Health Protection Agency.Epidemiological data; influenza [on\u2010line]. Available athttp:\/\/www.hpa.org.uk\/infections\/topics_az\/seasonal\/flureports0405\/graph01.pdfAccessed December 7 2006."},{"key":"e_1_2_7_23_2","unstructured":"Health Protection agency.Communicable Disease in London 2002\u20132005[on\u2010line]. Available athttp:\/\/www.hpa.org.uk\/publications\/2006\/communicable_london\/part1.pdf."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyi274"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.6333"},{"key":"e_1_2_7_26_2","first-page":"1165","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people","volume":"366","author":"Jefferson T","year":"2005","journal-title":"A systematic review"},{"key":"e_1_2_7_27_2","unstructured":"National Service Framework for Older People Standard 8. [on\u2010line]. Available athttp:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_4003066Accessed August 28 2007."}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2007.01471.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2007.01471.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:15:26Z","timestamp":1762182926000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2007.01471.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1532-5415.2007.01471.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01471.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"type":"print","value":"0002-8614"},{"type":"electronic","value":"1532-5415"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}